PolarityTE (PTEIQ) Competitors

$0.07
0.00 (0.00%)
(As of 05/10/2024 ET)

PTEIQ vs. PKBO, ATHX, AMPE, CALA, IGNY, MOTS, OBSV, SMFL, APVO, and SXTC

Should you be buying PolarityTE stock or one of its competitors? The main competitors of PolarityTE include Peak Bio (PKBO), Athersys (ATHX), Ampio Pharmaceuticals (AMPE), Calithera Biosciences (CALA), Ignyte Acquisition (IGNY), Motus GI (MOTS), ObsEva (OBSV), Smart for Life (SMFL), Aptevo Therapeutics (APVO), and China SXT Pharmaceuticals (SXTC). These companies are all part of the "medical" sector.

PolarityTE vs.

PolarityTE (NASDAQ:PTEIQ) and Peak Bio (NASDAQ:PKBO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

Peak Bio received 1 more outperform votes than PolarityTE when rated by MarketBeat users.

CompanyUnderperformOutperform
PolarityTEN/AN/A
Peak BioOutperform Votes
1
100.00%
Underperform Votes
No Votes

Peak Bio's return on equity of 0.00% beat PolarityTE's return on equity.

Company Net Margins Return on Equity Return on Assets
PolarityTEN/A -106.08% -76.91%
Peak Bio N/A N/A N/A

In the previous week, PolarityTE's average media sentiment score of 0.00 equaled Peak Bio'saverage media sentiment score.

Company Overall Sentiment
PolarityTE Neutral
Peak Bio Neutral

PolarityTE has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Peak Bio has a beta of 0.12, indicating that its share price is 88% less volatile than the S&P 500.

11.8% of PolarityTE shares are owned by institutional investors. 5.4% of PolarityTE shares are owned by insiders. Comparatively, 19.9% of Peak Bio shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

PolarityTE has higher revenue and earnings than Peak Bio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PolarityTE$810K0.63-$7.83M-$3.28-0.02
Peak Bio$610K0.32-$13.09MN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PolarityTE
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Peak Bio
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

PolarityTE beats Peak Bio on 5 of the 9 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTEIQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PTEIQ vs. The Competition

MetricPolarityTEBiotechnology IndustryMedical SectorNASDAQ Exchange
Market Cap$615,000.00$114.10M$5.12B$7.81B
Dividend YieldN/A3.48%38.15%3.92%
P/E Ratio-0.0281.54110.0715.84
Price / Sales0.6316,988.232,418.4274.83
Price / CashN/A11.6648.8335.50
Price / Book0.036.795.334.38
Net Income-$7.83M-$16.24M$106.58M$217.46M
7 Day PerformanceN/A0.33%-0.89%-0.14%
1 Month PerformanceN/A3.55%-1.39%0.05%
1 Year PerformanceN/A5.32%4.69%9.69%

PolarityTE Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PKBO
Peak Bio
0 of 5 stars
$0.01
flat
N/AN/A$192,000.00$610,000.000.0021High Trading Volume
ATHX
Athersys
0 of 5 stars
$0.00
flat
N/A-99.5%$265,000.00$146,000.000.0024Gap Up
AMPE
Ampio Pharmaceuticals
0 of 5 stars
$0.26
flat
N/A-94.3%$291,000.00N/A-0.026Upcoming Earnings
Analyst Forecast
CALA
Calithera Biosciences
0 of 5 stars
$0.02
flat
N/A-33.3%$97,000.00$9.75M0.008Analyst Forecast
IGNY
Ignyte Acquisition
0 of 5 stars
$0.01
flat
N/AN/A$62,000.00N/A0.00N/A
MOTS
Motus GI
1.3474 of 5 stars
$0.07
flat
$28.88
+40,004.2%
-99.4%$362,000.00$319,000.000.0015Gap Up
OBSV
ObsEva
0 of 5 stars
$0.01
flat
N/AN/A$390,000.00$20.11M-0.0148Gap Down
SMFL
Smart for Life
0 of 5 stars
$3.58
+7.8%
N/A-97.8%$394,000.00$17.77M0.00145Short Interest ↑
APVO
Aptevo Therapeutics
0.5365 of 5 stars
$0.99
-12.4%
N/A-98.8%$425,000.00$3.11M0.0040Short Interest ↑
Analyst Revision
SXTC
China SXT Pharmaceuticals
0 of 5 stars
$0.96
-4.9%
N/A-81.8%$439,000.00$1.70M0.0078Short Interest ↓

Related Companies and Tools

This page (NASDAQ:PTEIQ) was last updated on 5/12/2024 by MarketBeat.com Staff

From Our Partners